The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission

Clin Transl Med. 2021 Oct;11(10):e573. doi: 10.1002/ctm2.573.

José Avendaño-Ortiz^{1

2}, Roberto Lozano-Rodríguez^{1

2}, Alejandro Martín-Quirós³, Verónica Terrón^{1

2}, Charbel Maroun-Eid², Karla Montalbán-Hernández^{1

2}, Jaime Valentín-Quiroga^{1

2}, Miguel Ángel García-Garrido³, Elena Muñoz Del Val^{1

3}, Álvaro Del Balzo-Castillo^{1

3}, María Peinado³, Laura Gómez³, Carmen Herrero-Benito³, Carolina Rubio^{1

2}, José Carlos Casalvilla-Dueñas^{1

2}, Paloma Gómez-Campelo^{1

4}, Alejandro Pascual-Iglesias^{1

2}, Carlos Del Fresno^{1

2}, Luis A Aguirre^{1

2}, Eduardo López-Collazo^{1

2

5}

¹ The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.
² Tumor Immunology Laboratory, IdiPAZ, La Paz University Hospital, Madrid, Spain.
³ Emergency Department and Emergent Pathology Research Group, IdiPAZ La Paz University Hospital, Madrid, Spain.
⁴ Biobank Platform, IdiPAZ, La Paz University Hospital, Madrid, Spain.
⁵ CIBER of Respiratory Diseases (CIBERES), Madrid, Spain.

No abstract available

Publication types